🇺🇸 FDA
Pipeline program

URSODEOXYCHOLIC ACID

URSOPOL

Phase 2 small_molecule active

Quick answer

URSODEOXYCHOLIC ACID for Hepatorenal polycystic diseases is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
Hepatorenal polycystic diseases
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials